Literature DB >> 21918497

Acute removal of common sepsis mediators does not explain the effects of extracorporeal blood purification in experimental sepsis.

Zhi-Yong Peng1, Hong-Zhi Wang, Melinda J Carter, Morgan V Dileo, Jeffery V Bishop, Fei-Hu Zhou, Xiao-Yan Wen, Thomas Rimmelé, Kai Singbartl, William J Federspiel, Gilles Clermont, John A Kellum.   

Abstract

The effect of extracorporeal blood purification on clinical outcomes in sepsis is assumed to be related to modulation of plasma cytokine concentrations. To test this hypothesis directly, we treated rats that had a cecal ligation followed by puncture (a standard model of sepsis) with a modest dose of extracorporeal blood purification that did not result in acute changes in a panel of common cytokines associated with inflammation (TNF-α, IL-1β, IL-6, and IL-10). Pre- and immediate post-treatment levels of these cytokines were unchanged compared to the sham therapy of extracorporeal circulation without blood purifying sorbent. The overall survival to 7 days, however, was significantly better in animals that received extracorporeal blood purification compared to those with a sham procedure. This panel of common plasma cytokines along with alanine aminotransferase and creatinine was significantly lower 72 h following extracorporeal blood purification compared to sham-treated rats. Thus, the effects of this procedure on organ function and survival do not appear to be due solely to immediate changes in the usual measured circulating cytokines. These results may have important implications for the design and conduct of future trials in sepsis including defining alternative targets for extracorporeal blood purification and other therapies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21918497      PMCID: PMC3269547          DOI: 10.1038/ki.2011.320

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  35 in total

1.  Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock.

Authors:  P M Honore; J Jamez; M Wauthier; P A Lee; T Dugernier; B Pirenne; G Hanique; J R Matson
Journal:  Crit Care Med       Date:  2000-11       Impact factor: 7.598

Review 2.  Novel strategies for the treatment of sepsis.

Authors:  Niels C Riedemann; Ren-Feng Guo; Peter A Ward
Journal:  Nat Med       Date:  2003-05       Impact factor: 53.440

Review 3.  The pathophysiology and treatment of sepsis.

Authors:  Richard S Hotchkiss; Irene E Karl
Journal:  N Engl J Med       Date:  2003-01-09       Impact factor: 91.245

4.  Hemoadsorption therapy for sepsis syndromes.

Authors:  John A Kellum
Journal:  Crit Care Med       Date:  2003-01       Impact factor: 7.598

5.  Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.

Authors:  D C Angus; W T Linde-Zwirble; J Lidicker; G Clermont; J Carcillo; M R Pinsky
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

6.  A phase II randomized, controlled trial of continuous hemofiltration in sepsis.

Authors:  Louise Cole; Rinaldo Bellomo; Graeme Hart; Didier Journois; Piers Davenport; Peter Tipping; Claudio Ronco
Journal:  Crit Care Med       Date:  2002-01       Impact factor: 7.598

7.  The effect of intensive plasma water exchange by hemofiltration on hemodynamics and soluble mediators in canine endotoxemia.

Authors:  R Bellomo; J A Kellum; C R Gandhi; M R Pinsky; B Ondulik
Journal:  Am J Respir Crit Care Med       Date:  2000-05       Impact factor: 21.405

8.  A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection.

Authors:  Jean-Louis Vincent; Pierre-François Laterre; Jonathan Cohen; Hilmar Burchardi; Hajo Bruining; Francisco Alvarez Lerma; Xavier Wittebole; Daniel De Backer; Stephen Brett; Dolores Marzo; Haruji Nakamura; Stephanie John
Journal:  Shock       Date:  2005-05       Impact factor: 3.454

9.  A pilot study of coupled plasma filtration with adsorption in septic shock.

Authors:  Claudio Ronco; Alessandra Brendolan; Gerhard Lonnemann; Rinaldo Bellomo; Pasquale Piccinni; Antonio Digito; Maurizio Dan; Marco Irone; Giuseppe La Greca; Paola Inguaggiato; Umberto Maggiore; Concetta De Nitti; Mary Lou Wratten; Zaccaria Ricci; Ciro Tetta
Journal:  Crit Care Med       Date:  2002-06       Impact factor: 7.598

Review 10.  Clinical review: extracorporeal blood purification in severe sepsis.

Authors:  Ramesh Venkataraman; Sanjay Subramanian; John A Kellum
Journal:  Crit Care       Date:  2003-02-21       Impact factor: 9.097

View more
  28 in total

1.  Effects of hemoadsorption with a novel adsorbent on sepsis: in vivo and in vitro study.

Authors:  Jicheng Zhang; Zhiyong Peng; Donald Maberry; Jacob Volpe; Jeremy D Kimmel; William J Federspiel; John A Kellum
Journal:  Blood Purif       Date:  2015-04-01       Impact factor: 2.614

Review 2.  Blood purification and mortality in sepsis: a meta-analysis of randomized trials.

Authors:  Feihu Zhou; Zhiyong Peng; Raghavan Murugan; John A Kellum
Journal:  Crit Care Med       Date:  2013-09       Impact factor: 7.598

3.  Purification methods: a way to treat severe acute inflammation related to sepsis?

Authors:  Anne Claire Lukaszewicz; Didier Payen
Journal:  Crit Care       Date:  2013-06-21       Impact factor: 9.097

4.  Effects of fluid resuscitation with 0.9% saline versus a balanced electrolyte solution on acute kidney injury in a rat model of sepsis*.

Authors:  Feihu Zhou; Zhi-Yong Peng; Jeffery V Bishop; Matthew E Cove; Kai Singbartl; John A Kellum
Journal:  Crit Care Med       Date:  2014-04       Impact factor: 7.598

5.  Development of venovenous extracorporeal blood purification circuits in rodents for sepsis.

Authors:  Zhi-Yong Peng; Jicheng Zhang; Thomas Rimmelé; Feihu Zhou; Anan Chuasuwan; A Murat Kaynar; John A Kellum
Journal:  J Surg Res       Date:  2013-08-06       Impact factor: 2.192

6.  Extracorporeal cytokine elimination as rescue therapy in refractory septic shock: a prospective single-center study.

Authors:  Sigrun Friesecke; Stephanie-Susanne Stecher; Stefan Gross; Stephan B Felix; Axel Nierhaus
Journal:  J Artif Organs       Date:  2017-06-06       Impact factor: 1.731

7.  A bio-artificial renal epithelial cell system conveys survival advantage in a porcine model of septic shock.

Authors:  Angela J Westover; Deborah A Buffington; Kimberly A Johnston; Peter L Smith; Christopher J Pino; H David Humes
Journal:  J Tissue Eng Regen Med       Date:  2014-11-25       Impact factor: 3.963

Review 8.  Sepsis-induced acute kidney injury revisited: pathophysiology, prevention and future therapies.

Authors:  Alexander Zarbock; Hernando Gomez; John A Kellum
Journal:  Curr Opin Crit Care       Date:  2014-12       Impact factor: 3.687

9.  Effect of cytokine hemoadsorption on brain death-induced ventricular dysfunction in a porcine model.

Authors:  Krasimira M Mikhova; Creighton W Don; Michael Laflamme; John A Kellum; Michael S Mulligan; Edward D Verrier; David G Rabkin
Journal:  J Thorac Cardiovasc Surg       Date:  2012-11-03       Impact factor: 5.209

10.  Broad spectrum immunomodulation using biomimetic blood cell margination for sepsis therapy.

Authors:  Han Wei Hou; Lidan Wu; Diana P Amador-Munoz; Miguel Pinilla Vera; Anna Coronata; Joshua A Englert; Bruce D Levy; Rebecca M Baron; Jongyoon Han
Journal:  Lab Chip       Date:  2016-01-15       Impact factor: 6.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.